Inactive Total Small Business Set-Aside (FAR 19.5)

THIS IS A SOURCES SOUGHT ANNOUNCEMENT, A MARKET SURVEY FOR WRITTEN INFORMATION ONLY. THIS IS NOT A SOLICITATION ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED FROM THIS ANNOUNCEMENT. NO RE... THIS IS A SOURCES SOUGHT ANNOUNCEMENT, A MARKET SURVEY FOR WRITTEN INFORMATION ONLY. THIS IS NOT A SOLICITATION ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED FROM THIS ANNOUNCEMENT. NO REIMBURSEMENT WILL BE MADE FOR ANY COSTS ASSOCIATED WITH PROVIDING INFORMATION IN RESPONSE TO THIS ANNOUNCEMENT OR ANY FOLLOW-UP INFORMATION REQUESTS. NO TELEPHONE CALLS WILL BE ACCEPTED REQUESTING AN RFQ PACKAGE OR SOLICITATION. THERE IS NO RFQ PACKAGE OR SOLICITATION. IN ORDER TO PROTECT THE PROCUREMENT INTEGRITY OF ANY FUTURE PROCUREMENT, IF ANY, THAT MAY ARISE FROM THIS ANNOUNCEMENT, INFORMATION REGARDING THE TECHNICAL POINT OF CONTACT WILL NOT BE GIVEN AND NO APPOINTMENTS FOR PRESENTATIONS WILL BE MADE. The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS) has issued this sources sought announcement on behalf of the Seattle Human and Animal Food Laboratory (SEAHAF) in order to determine if there are existing small business sources capable of providing Consumable Gases and Related Products for Laboratory Use. If your firm is considered a small business source under North American Industry Classification System (NAICS) Code 325120- Industrial Gas Manufacturing; with a Small Business Size Standard of 1200 employees and believe that your firm would be able to provide the FDA with the supplies/services described below, please submit an email to Nina.Montgomery@fda.hhs.gov. The vendor should include information about the company and demonstrate that it can meet all of the minimum performance requirements. Interested Contractors must respond with capability statements which are due by email to the point of contact listed below on or before July 24, 2024 by 12:00pm (EST) at the Food and Drug Administration, Attn: Nina Montgomery, email nina.montgomery@fda.hhs.gov. Reference: 75F40124Q121425.